News

Use of AI-drafted clinical notes from clinician-patient conversations also improves perceived documentation-related well-being.
HealthDay News — Prenatal exposure to the pesticide chlorpyrifos (CPF) is associated with altered differentiation of neuronal tissue, increased myelination of the internal capsule, and lower regional ...
The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous ...
In October 2024, Imuldosa received approval from the Food and Drug Administration based on data from the phase 3 Opportuniti ...
OTC access linked to 31.8 percentage point increase in individuals moving from no contraceptive method to an effective method.
HealthDay News — For patients 50 years or older at high cardiovascular risk without diabetes or prior stroke, an intensive systolic blood pressure (SBP) target (<120 mm Hg) seems cost-effective ...
Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education ...
Dawnzera, a prekallikrein-directed antisense oligonucleotide, is supplied as a 80mg/0.8mL solution in a single-dose autoinjector.
The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of fibromyalgia.
AA clinical program includes 2 replicate pivotal studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.
The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.